280 related articles for article (PubMed ID: 28623239)
1. (CCUG)
Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
[TBL] [Abstract][Full Text] [Related]
2. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
[TBL] [Abstract][Full Text] [Related]
3. Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.
Machuca-Tzili L; Thorpe H; Robinson TE; Sewry C; Brook JD
Hum Genet; 2006 Nov; 120(4):487-99. PubMed ID: 16927100
[TBL] [Abstract][Full Text] [Related]
4. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
[TBL] [Abstract][Full Text] [Related]
5. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
7. A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1.
Yu Z; Goodman LD; Shieh SY; Min M; Teng X; Zhu Y; Bonini NM
Hum Mol Genet; 2015 Feb; 24(4):954-62. PubMed ID: 25305073
[TBL] [Abstract][Full Text] [Related]
8. Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2.
Timchenko L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142405
[TBL] [Abstract][Full Text] [Related]
9. RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.
Jones K; Jin B; Iakova P; Huichalaf C; Sarkar P; Schneider-Gold C; Schoser B; Meola G; Shyu AB; Timchenko N; Timchenko L
Am J Pathol; 2011 Nov; 179(5):2475-89. PubMed ID: 21889481
[TBL] [Abstract][Full Text] [Related]
10. Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.
Chakraborty M; Selma-Soriano E; Magny E; Couso JP; Pérez-Alonso M; Charlet-Berguerand N; Artero R; Llamusi B
Dis Model Mech; 2015 Dec; 8(12):1569-78. PubMed ID: 26515653
[TBL] [Abstract][Full Text] [Related]
11. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
12. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
[TBL] [Abstract][Full Text] [Related]
13. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
Sznajder ŁJ; Swanson MS
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323950
[TBL] [Abstract][Full Text] [Related]
14. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
[TBL] [Abstract][Full Text] [Related]
15. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of protein homeostasis in myotonic dystrophies.
Meola G; Jones K; Wei C; Timchenko LT
Histol Histopathol; 2013 Sep; 28(9):1089-98. PubMed ID: 23536431
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
18. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model.
Bargiela A; Cerro-Herreros E; Fernandez-Costa JM; Vilchez JJ; Llamusi B; Artero R
Dis Model Mech; 2015 Jul; 8(7):679-90. PubMed ID: 26092529
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
20. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.
Llamusi B; Bargiela A; Fernandez-Costa JM; Garcia-Lopez A; Klima R; Feiguin F; Artero R
Dis Model Mech; 2013 Jan; 6(1):184-96. PubMed ID: 23118342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
